Regenacy

Developer of therapies for treating diabetic and other peripheral nephropathy

placeWaltham, Massachusetts, United States calendar_todayFounded 2016 groups5 employees language regenacy.com

Registered entities

Investor mix

9 investors on record; lead investors include Cobro Ventures, Taiwania Capital.

Investor typeCountShare
Venture capital778%
Angel & family office111%
Other / undisclosed111%
Coming soon